Published Study Details Proof-of-Concept for COVID-19 Detection via Saliva Screening

Author's Avatar
Feb 23, 2022

Agilent+Technologies+Inc. (NYSE: A) announced today that researchers from the QIMR+Berghofer+Medical+Research+Institute in Brisbane, Australia, collaborated with Agilent experts on a proof-of-concept FTIR-based saliva COVID-19 testing workflow using the Agilent+Cary+630+FTIR+Spectrometer.